Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Revenue (2016 - 2025)

Historic Revenue for vTv Therapeutics (VTVT) over the last 10 years, with Q4 2024 value amounting to $17000.0.

  • vTv Therapeutics' Revenue changed N/A to $17000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $17000.0, marking a year-over-year decrease of 9830.0%. This contributed to the annual value of $1.0 million for FY2024, which is N/A changed from last year.
  • Per vTv Therapeutics' latest filing, its Revenue stood at $17000.0 for Q4 2024.
  • vTv Therapeutics' Revenue's 5-year high stood at $6.4 million during Q4 2020, with a 5-year trough of $7000.0 in Q3 2020.
  • Over the past 4 years, vTv Therapeutics' median Revenue value was $13000.0 (recorded in 2021), while the average stood at $1.1 million.
  • In the last 5 years, vTv Therapeutics' Revenue surged by 9131428.57% in 2020 and then crashed by 9985.94% in 2021.
  • Quarter analysis of 4 years shows vTv Therapeutics' Revenue stood at $6.4 million in 2020, then crashed by 99.86% to $9000.0 in 2021, then changed by 0.0% to $9000.0 in 2022, then soared by 88.89% to $17000.0 in 2024.
  • Its last three reported values are $17000.0 in Q4 2024, $1.0 million for Q1 2024, and $9000.0 during Q4 2022.